Booster vaccination against the SARS-CoV-2: mechanisms and efficiency

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency

Coronavirus disease 2019 (COVID-19) pandemic was not only a serious challenge for the healthcare system around the world, but also an incentive for intensive research and development for the introduction of innovative technologies and drugs, in particular vaccines against the Severe Acute Respirator...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. A. Berns, A. V. Veremeyev, A. A. Savicheva, A. Yu. Gorshkov, O. M. Drapkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2023-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	covid-19 vaccination booster vaccine immunity immune response sars-cov-2 pandemic
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3820
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
by: F. D. Partey, et al.
Published: (2025-07-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

COVID-19 incidence after vaccination with different types of vaccines against SARS-CoV-2
by: O. M. Drapkina, et al.
Published: (2025-02-01)

Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters
by: Kabita Adhikari, et al.
Published: (2025-06-01)

From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)

Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
by: Huijie Yang, et al.
Published: (2024-12-01)

Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study
by: María Jesús López, et al.
Published: (2025-12-01)

Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
by: Yichuan Yao, et al.
Published: (2025-01-01)

Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff
by: M. P. Kostinov, et al.
Published: (2025-01-01)

Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history
by: Rui Wang, et al.
Published: (2025-08-01)

Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants
by: Busra Kaplan, et al.
Published: (2025-02-01)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024-12-01)

COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
by: Seul Gee Park, et al.
Published: (2023-12-01)

Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
by: A. V. Ivanov, et al.
Published: (2024-11-01)

Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron
by: Andrew H. Karaba, et al.
Published: (2025-02-01)

Analysis of the humoral and cell-mediated immune response in heterologous and homologous SARS-CoV-2 revaccination
by: O. M. Drapkina, et al.
Published: (2023-11-01)

Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls
by: Vitor Gabriel Lopes da Silva, et al.
Published: (2025-03-01)

Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
by: John T. Bates, et al.
Published: (2024-12-01)

Seroprevalence and influencing factors of low-level neutralizing antibodies against SARS-CoV-2 in community residents
by: YUAN Shiying, et al.
Published: (2025-05-01)

The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
by: Adam Tworek, et al.
Published: (2023-03-01)

Vaccination against SARS-COV‑2 in oncology
by: A. A. Polyakov, et al.
Published: (2021-06-01)

Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine boosters in preventing fatal outcomes among severe COVID-19 cases during the current ambit of SARS-CoV-2 XBB and JN.1 variant circulation
by: Eugene S. K. Lo, et al.
Published: (2025-05-01)

Reinfection with SARS-CoV-2 variants: The issues of hybrid immunity efficiency
by: I. A. Pobozhaya, et al.
Published: (2025-06-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response
by: Ali Toloue Ostadgavahi, et al.
Published: (2021-05-01)

Pulmonary embolism after SARS-CoV-2 vaccination
by: Björn Zethelius, et al.
Published: (2024-12-01)

Effect of recent SARS-CoV-2 infection on anti-spike protein immunoglobulin G II response after BNT162b2 vaccination
by: Daiki Tanno, et al.
Published: (2025-08-01)

Identifying influential factors using machine learning techniques on the intention to receive a COVID-19 booster dose and vaccine fatigue among partially vaccinated individuals
by: Athina Bikaki, et al.
Published: (2024-11-01)

Recent developments in the therapeutics of SARS-CoV-2 infection
by: Priyanka Nagu, et al.
Published: (2024-12-01)

Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses
by: Beatriz L. L. Caetano, et al.
Published: (2025-08-01)

Antibody Kinetics of Immunological Memory in SARS-CoV-2-Vaccinated Healthcare Workers—The ORCHESTRA Project
by: Seyedalireza Seyedi, et al.
Published: (2025-06-01)

SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study
by: Keltyn Oliveira, et al.
Published: (2024-11-01)

Severity and duration of immune response in people of different age categories after SARS-CoV-2 revaccination
by: O. M. Drapkina, et al.
Published: (2023-12-01)

Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
by: Jesse M. van den Berg, et al.
Published: (2025-05-01)

Analysis of Vaccination Background in Children Undergone SARS-CoV-2 Infection
by: Marina V. Fedoseenko, et al.
Published: (2021-01-01)

SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients
by: Euri Seo, et al.
Published: (2024-12-01)

Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants
by: Chaofeng Liang, et al.
Published: (2025-07-01)

Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
by: Xiuwen Wang, et al.
Published: (2025-02-01)

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
by: Rahul K. Suryawanshi, et al.
Published: (2023-12-01)